Brazil Lula shock slams EMMonday opens with no single unifying thread—just a messy mix of an overnight Brazil election s…

Brazil Lula shock slams EM

Monday opens with no single unifying thread—just a messy mix of an overnight Brazil election shock slamming EM assets, oil pulling back from six-month highs on de-escalation hopes (while Houthi/Saudi and Iran tensions linger), futures modestly green into a packed central-bank and mega-cap earnings week, and a handful of single-stock catalysts. Don’t force a thesis.

Brazil: Lula Re-Election Shock Hits Markets

★ MOST ACTIONABLE · ▼ NEGATIVE · $EWZ $XP(XP.US) $NU Holdings(NU.US) $Itau Unibanco Banco Mult(ITUB.US) $Petroleo Brasileiro SA(PBR.US) $Vale SA(VALE.US)

Lula da Silva defeated Flávio Bolsonaro ~52-48% in the runoff. Markets had priced a more market-friendly outcome and fiscal pivot; the surprise win sparked an immediate repricing.

$EWZ (MSCI Brazil ETF) plunged ~20-26% in pre-market/after-hours, on pace for one of its worst single-day moves since inception.

Brazilian ADRs crushed: $XP(XP.US) -45%+, $NU Holdings(NU.US) -23%, $Itau Unibanco Banco Mult(ITUB.US) -25%+, $StoneCo(STNE.US)/$Pagseguro Digital(PAGS.US) similarly heavy, $Petroleo Brasileiro SA(PBR.US) -20% range, $Vale SA(VALE.US) milder (~-5%). Financials and domestic-facing names led the bloodbath; exporters cushioned somewhat by a weaker real.

European exposure also hit: Santander, Telefónica, and Mapfre under pressure on the open.

Expert take: Analysts and desks expected a sharp correction (some flagged possible circuit-breaker risk on the local open). Goldman and others had sketched extreme scenarios of real weakness and higher local rates. The narrative on FinTwit is classic “socialist fiscal risk kills the bid”—investors had piled into the Bolsonaro/liberal agenda trade after the first round. Near-term, watch for forced selling, real depreciation, and whether any policy olive branches emerge. This is a classic EM political gap-risk event that can spill into broader risk appetite if it deepens.

Macro / Oil / Central Banks

Oil is the near-term relief valve. Brent and WTI pulled back ~1.5-2%+ overnight from Friday’s six-month highs (Brent ~$116.72, WTI ~$103) after weekend Houthi attacks on Saudi energy/airport targets and continued Hormuz tanker risks. Diplomatic mediation (Qatar, others heading to Tehran) plus Trump comments that a decision on deal-vs-strikes is near provided the pullback. Geopolitical risk premium remains elevated; any re-escalation (post-US midterms or Israeli politics) can reverse this quickly.

US futures modestly green into the open (S&P ~+0.3%, Nasdaq ~+0.2%). This week is the real event: Fed expected to hold at 3.75-4.00% on Wednesday (after the September hike), with the debate shifting to December guidance and the tone from Chair Warsh. ECB and BoJ also on deck. Hot growth (PMIs, upcoming Q3 GDP) + sticky inflation keep a further hike live later. Light Monday data (Chicago/Dallas Fed).

Earnings Week Setup

The densest stretch of the season is still ahead. Monday is relatively quiet: $Verizon(VZ.US) before the open (consensus ~$1.27 EPS / ~$34.7-35B revenue; focus on postpaid adds, churn, FCF, and how they address SpaceX spectrum competition). After close: $Cadence Design(CDNS.US), $NU Holdings(NU.US)E, $Welltower Op(WELL.US) and others.

Big ones later: $Microsoft(MSFT.US) and $Alphabet(GOOGL.US) Wednesday, $Amazon(AMZN.US)/$Intel(INTC.US) Thursday, $ExxonMobil(XOM.US)/$Chevron(CVX.US) Friday. Options and positioning are elevated. The AI capex narrative remains the dominant overhang after $Meta Platforms(META.US)’s print (raised 2026 capex to $135-145B, Q3 FCF negative, new Class C stock for funding). Bears continue to flag ROI timing and circular financing risks; bulls argue demand is still there but funding/cost of capital is the new constraint. Watch how the mega-caps address this.

SGRY: M&A Bid

▲ POSITIVE · $Surgery Partners(SGRY.US)

Premarket surge (~+20%) on FT reports that Bon Secours Mercy Health is in late-stage talks for a majority stake, valuing the outpatient surgery platform at ~$6B (including debt), or roughly $20/share—a solid premium to recent levels. Bain is expected to roll its stake. Could be announced as soon as today. Classic catalyst trade on a take-private.

Other Standalone Items

$SpaceX(SPCX.US) (SpaceX) continues to trade as the high-beta AI + connectivity story (strong recent print with AI revenue contribution, spectrum deal that previously hit $AT & T(T.US)/$Verizon(VZ.US)/$AT & T(T.US)MUS, and ongoing Tesla merger committee talk). $AT & T(T.US)SLA benefits from the optionality. Towers ($Crown Castle(CCI.US)/$SBA Communications(SBAC.US)) had already reacted positively earlier.

Anthropic S-1: the public filing was reportedly planned for 9:00 a.m. ET today. Earlier reports on the draft described about $518B in compute commitments, including roughly $161B to Broadcom, $111B to Google and $110B to Amazon. They also showed $16.3B of first-half revenue and about 20% of revenue coming from the top two customers. That could move AVGO, GOOGL and AMZN.

$Meta Platforms(META.US) financing: META launched $35B in offerings: $22.5B of common stock through forward sales plus $12.5B of mandatory convertible preferred. A $60B at-the-market program would follow in Q1 2027. NVDA, AMD and AVGO have indicated interest in buying up to $5B of the stock, though none has committed. The stock fell $20 and then recovered to positive.

$Moderna(MRNA.US): the stock is still selling off after the Phase 3 melanoma vaccine results (with Merck). The vaccine cut recurrence risk by 42%, below the 49% from the Phase 2b study, and the stock had run more than 500% this year. One technical writeup puts support at 181.36, with 173.13 next and 209.59 as the trigger for a recovery. Moderna reports Q3 on November 6

Gold holding near the $4,000 area after a recent dip.

Bottom line for swing traders: The Brazil gap is the highest-conviction short-term catalyst (volume + narrative). Oil pullback and modest futures give some risk-on breathing room into the open, but the real volatility arrives mid-week with the Fed and mega-cap prints. Size for drawdowns—especially around the AI capex debate and any geopolitical headline risk.

NFA / DYOR.